Waters Corporation Stock

Equities

WAT

US9418481035

Advanced Medical Equipment & Technology

Market Closed - Nyse 04:00:01 2024-04-19 pm EDT 5-day change 1st Jan Change
296.1 USD +0.64% Intraday chart for Waters Corporation -8.23% -10.06%
Sales 2024 * 2.98B Sales 2025 * 3.17B Capitalization 17.56B
Net income 2024 * 658M Net income 2025 * 727M EV / Sales 2024 * 6.35 x
Net Debt 2024 * 1.37B Net Debt 2025 * 1.1B EV / Sales 2025 * 5.89 x
P/E ratio 2024 *
26.8 x
P/E ratio 2025 *
24 x
Employees 7,900
Yield 2024 *
-
Yield 2025 *
-
Free-Float 36.4%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.64%
1 week-8.23%
Current month-13.98%
1 month-15.15%
3 months-5.23%
6 months+17.35%
Current year-10.06%
More quotes
1 week
288.94
Extreme 288.94
328.11
1 month
288.94
Extreme 288.94
355.70
Current year
288.94
Extreme 288.94
363.80
1 year
231.90
Extreme 231.9
363.80
3 years
231.90
Extreme 231.9
428.22
5 years
154.39
Extreme 154.39
428.22
10 years
93.56
Extreme 93.56
428.22
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 20-08-31
Director of Finance/CFO 48 21-05-11
Chief Operating Officer - 21-12-31
Members of the board TitleAgeSince
Director/Board Member 63 18-08-31
Director/Board Member 67 23-03-26
Director/Board Member 70 06-04-30
More insiders
Date Price Change Volume
24-04-19 296.1 +0.64% 466,321
24-04-18 294.2 -3.27% 687,011
24-04-17 304.2 -3.04% 614,608
24-04-16 313.7 -1.84% 441,693
24-04-15 319.6 -0.95% 312,519

Delayed Quote Nyse, April 19, 2024 at 04:00 pm EDT

More quotes
Waters Corporation specializes in the conception, the manufacturing and the marketing of analytical instruments. Net sales break down by activity as follows: - sale of instruments and analytical systems (63.6%): chromatographic analysis instruments (59.5% of net sales; instruments high performance liquid chromatography and mass spectrometry), chemistry consumables (28.9%; including columns chemical separation) and thermal analysis, rheometry and calorimetry instruments (11.6%) ; - services (36.7%): support services, training, etc. Net sales are distributed by market between pharmaceutical (58.6%), industrial (29.9%), academic institutions and governmental agencies (11.4%). Net sales are distributed geographically as follows: the United States (28.7%), Americas (5.1%), China (17.1%), Japan (7.6%), Asia (13.3%) and Europe (28.2%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
296.1 USD
Average target price
325.3 USD
Spread / Average Target
+9.86%
Consensus